CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 35 filers reported holding CONMED CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,259,585 | +21.6% | 6,020,000 | -2.9% | 0.26% | +23.9% |
| Q1 2023 | $7,615,069 | +6.9% | 6,198,000 | -1.4% | 0.21% | +14.8% |
| Q4 2022 | $7,123,996 | -1.8% | 6,287,000 | -5.0% | 0.18% | -0.5% |
| Q3 2022 | $7,255,000 | -11.5% | 6,619,000 | -2.4% | 0.18% | -8.0% |
| Q2 2022 | $8,195,000 | -87.5% | 6,783,000 | -82.2% | 0.20% | -65.4% |
| Q1 2022 | $65,472,000 | +3.7% | 38,008,000 | +0.3% | 0.58% | +9.5% |
| Q4 2021 | $63,163,000 | +6.3% | 37,899,000 | -1.1% | 0.52% | -6.2% |
| Q3 2021 | $59,400,000 | -4.0% | 38,329,000 | +0.1% | 0.56% | -3.6% |
| Q2 2021 | $61,845,000 | +11.0% | 38,286,000 | +7.7% | 0.58% | +43.1% |
| Q1 2021 | $55,708,000 | +22.7% | 35,548,000 | +9.8% | 0.41% | +29.7% |
| Q4 2020 | $45,397,000 | +42.2% | 32,384,000 | +14.1% | 0.31% | +44.2% |
| Q3 2020 | $31,930,000 | +8.4% | 28,394,000 | +1.4% | 0.22% | -7.7% |
| Q2 2020 | $29,448,000 | +13.2% | 28,004,000 | +0.2% | 0.24% | -2.5% |
| Q1 2020 | $26,009,000 | – | 27,947,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 50,065,000 | $86,599,000 | 6.97% |
| III Capital Management | 12,488,000 | $21,464,000 | 1.87% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $6,946,000 | 1.55% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,082,000 | $10,261,000 | 1.29% |
| SSI INVESTMENT MANAGEMENT LLC | 6,448,000 | $11,078,000 | 0.60% |
| MACKAY SHIELDS LLC | 38,008,000 | $65,472,000 | 0.58% |
| Eisler Capital (UK) Ltd. | 9,500,000 | $16,280,000 | 0.27% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 53,974,000 | $93,024,000 | 0.26% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 2,607,000 | $4,493,000 | 0.25% |
| Polar Asset Management Partners Inc. | 10,000,000 | $17,137,000 | 0.18% |